Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q2

3055.TEDINET S100PK8H
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥129.4bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥122.0bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥1.1bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥759m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥1.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥2.1bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥1.7bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.2bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥140.6bnat 2022-09-30Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥137.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥83.9bnat 2022-09-30Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥56.6bnat 2022-09-30Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥55.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥21.4bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.6bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥122m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥224m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥633m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥648m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥62.942022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.062021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.172021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio40.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.5%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥30m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥910m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥848m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥217m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥631m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥20m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥33.0bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥32.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥251m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥777m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥172m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥92.3bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥87.7bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥347m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥136.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥129.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥2.2bn
Otherother segmentsrevenue2021-04-01 → 2021-09-30¥1.0bn
Otherother segmentsrevenue external2021-04-01 → 2021-09-30¥30m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥991m
Otherother segmentssegment profit2021-04-01 → 2021-09-30¥345m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥7m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥40m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥675m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥217m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥457m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥28m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥30.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥30.4bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥237m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥572m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥1.9bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.9bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥157m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥87.2bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥82.8bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥113m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥128.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥122.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 550
ItemContextValueUnit
Provision for bonusesPrior1YearInstant860000000JPY
Provision for bonusesCurrentQuarterInstant1020000000JPY
Provision for directors bonusesPrior1YearInstant131000000JPY
Provision for directors bonusesCurrentQuarterInstant57000000JPY
Other clPrior1YearInstant2477000000JPY
Other clCurrentQuarterInstant2010000000JPY
Current liabilitiesPrior1YearInstant78214000000JPY
Current liabilitiesCurrentQuarterInstant80848000000JPY
Long term loans payablePrior1YearInstant16000000JPY
Long term loans payableCurrentQuarterInstant15000000JPY
Deferred tax liabilitiesPrior1YearInstant1510000000JPY
Deferred tax liabilitiesCurrentQuarterInstant1497000000JPY
Deferred tax liabilities for land revaluationPrior1YearInstant120000000JPY
Deferred tax liabilities for land revaluationCurrentQuarterInstant120000000JPY
Net defined benefit liabilityPrior1YearInstant367000000JPY
Net defined benefit liabilityCurrentQuarterInstant337000000JPY
Long term accounts payable otherPrior1YearInstant397000000JPY
Long term accounts payable otherCurrentQuarterInstant389000000JPY
Asset retirement obligations nclPrior1YearInstant488000000JPY
Asset retirement obligations nclCurrentQuarterInstant493000000JPY
Other nclPrior1YearInstant224000000JPY
Other nclCurrentQuarterInstant232000000JPY
Noncurrent liabilitiesPrior1YearInstant3125000000JPY
Noncurrent liabilitiesCurrentQuarterInstant3087000000JPY
LiabilitiesPrior1YearInstant81340000000JPY
LiabilitiesCurrentQuarterInstant83935000000JPY
Capital stockPrior1YearInstant1000000000JPY
Capital stockCurrentQuarterInstant1000000000JPY
Capital surplusPrior1YearInstant11821000000JPY
Capital surplusCurrentQuarterInstant11821000000JPY
Retained earningsPrior1YearInstant38965000000JPY
Retained earningsCurrentQuarterInstant40152000000JPY
Treasury stockPrior1YearInstant-1325000000JPY
Treasury stockCurrentQuarterInstant-1709000000JPY
Shareholders equityPrior1YearInstant50461000000JPY
Shareholders equityCurrentQuarterInstant51264000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5909000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6202000000JPY
Revaluation reserve for landPrior1YearInstant-742000000JPY
Revaluation reserve for landCurrentQuarterInstant-742000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-96000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-86000000JPY
Valuation and translation adjustmentsPrior1YearInstant5070000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant5373000000JPY
Non controlling interestsPrior1YearInstant11000000JPY
Non controlling interestsCurrentQuarterInstant12000000JPY
Net assetsPrior1YearInstant55543000000JPY
Net assetsCurrentQuarterInstant56650000000JPY
Liabilities and net assetsPrior1YearInstant136883000000JPY
Liabilities and net assetsCurrentQuarterInstant140586000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass